← Back to catalogue

Stat Profile

FDA UDI

Class II (US FDA UDI)

by Nova Biomedical Corporation

Identity

Trade Name
STAT PROFILE FDA UDI
Generic Name
Metabolic profile clinical chemistry analyser IVD, portable, semi-automated FDA UDI
Device Name
Prime Sensor Card CCS FDA UDI
Model / Reference
PRIME CCS FDA UDI
Description
Prime Sensor Card CCS FDA UDI

Identifiers

Catalog Number
42032 FDA UDI
Primary DI / UDI-DI
00385480420327 FDA UDI
510(k) Number
K141907 FDA UDI
FDA Product Code
CGZ FDA UDI
GKF FDA UDI
JGS FDA UDI
CHL FDA UDI
CGA FDA UDI
CEM FDA UDI
JIX FDA UDI
JJS FDA UDI
KHP FDA UDI
JFP FDA UDI
GMDN Term
Metabolic profile clinical chemistry analyser IVD, portable, semi-automated FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1170 FDA UDI
864.5600 FDA UDI
862.1665 FDA UDI
862.1120 FDA UDI
862.1345 FDA UDI
862.1600 FDA UDI
862.1150 FDA UDI
862.1660 FDA UDI
862.1450 FDA UDI
862.1145 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Metabolic profile clinical chemistry analyser IVD, portable, semi-automated

Stat Profile by Nova Biomedical Corporation — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Metabolic profile clinical chemistry analyser IVD, portable, semi-automated.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 40603d8c-ac20-4a85-b51c-03ee6b178bb3 37 fields · synced Jun 8, 2026